Wendel


NAV recovery masks weak underlying momentum

22/10/26 -"Wendel’s Q3 update was mixed, with NAV up 5.1% QoQ to €167 per share, largely supported by recovering market multiples rather than underlying value creation. Wendel IM delivered 10% organic ..."

Pages
65
Language
English
Published on
22/10/26
You may also be interested by these reports :
22/10/26
Wendel’s Q3 update was mixed, with NAV up 5.1% QoQ to €167 per share, largely supported by recovering market multiples rather than underlying value ...

21/10/26
Deutsche Börse’s Q3-26 beat EBITDA consensus by 3%, with net revenue ex-treasury up 14% (from +9% in Q2), roughly three-quarters structural. ...

21/10/26
Edenred delivered a Q3 revenue beat on both operating and other revenue, with intrinsic growth of +6.6% absorbing the Brazilian decree, and ...

21/10/26
Our EPS for 2026 mainly suffers from the steep consensus cut on UMG projected net income for 2026, leading us to forecast a c.€35m lower income from ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO